Trials / Completed
CompletedNCT00257413
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- —
Summary
Experimental data suggest that transplantation of endothelial progenitor cells (EPCs) attenuates monocrotaline-induced pulmonary hypertension in rats and dogs. In addition, clinical studies suggest that autogolous progenitor cells transplantation is feasible and safe in patients with ischemic disease. This study will investigate the feasibility, safety, and initial clinical outcome of intravenous infusion of autologous EPCs in patients with idiopathic pulmonary arterial hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transplantation of autologous endothelial progenitor cells |
Timeline
- First posted
- 2005-11-22
- Last updated
- 2005-11-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00257413. Inclusion in this directory is not an endorsement.